These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 11811968)

  • 1. Enzyme-linked immunosorbent assay for distinct cyclin-dependent kinase activities using phosphorylation-site-specific anti-pRB monoclonal antibodies.
    Suzuki S; Tamai K; Yoshida S
    Anal Biochem; 2002 Feb; 301(1):65-74. PubMed ID: 11811968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity.
    Horton LE; Templeton DJ
    Oncogene; 1997 Jan; 14(4):491-8. PubMed ID: 9053846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies specific for underphosphorylated retinoblastoma protein identify a cell cycle regulated phosphorylation site targeted by CDKs.
    Zarkowska T; U S; Harlow E; Mittnacht S
    Oncogene; 1997 Jan; 14(2):249-54. PubMed ID: 9010227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.
    Takaki T; Fukasawa K; Suzuki-Takahashi I; Semba K; Kitagawa M; Taya Y; Hirai H
    J Biochem; 2005 Mar; 137(3):381-6. PubMed ID: 15809340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro.
    Takaki T; Fukasawa K; Suzuki-Takahashi I; Hirai H
    Biochem Biophys Res Commun; 2004 Mar; 316(1):252-5. PubMed ID: 15003538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-type cyclins and G1 progression during liver development in the rat.
    Boylan JM; Gruppuso PA
    Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip].
    Malashicheva AB; Kisliakova TV; Pospelov VA
    Tsitologiia; 2002; 44(7):649-55. PubMed ID: 12455373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
    Touyz RM; Yao G
    J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four distinct cyclin-dependent kinases phosphorylate histone H1 at all of its growth-related phosphorylation sites.
    Swank RA; Th'ng JP; Guo XW; Valdez J; Bradbury EM; Gurley LR
    Biochemistry; 1997 Nov; 36(45):13761-8. PubMed ID: 9374852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of retinoblastoma susceptibility gene protein assayed in individual lymphocytes during their mitogenic stimulation.
    Juan G; Gruenwald S; Darzynkiewicz Z
    Exp Cell Res; 1998 Feb; 239(1):104-10. PubMed ID: 9511729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells.
    Yoshida J; Ishibashi T; Nishio M
    Biochem Pharmacol; 2007 Apr; 73(7):943-53. PubMed ID: 17217918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone-treated MCF-7 breast cancer cells.
    Ahamed S; Foster JS; Bukovsky A; Diehl JA; Wimalasena J
    Mol Carcinog; 2002 May; 34(1):45-58. PubMed ID: 12112322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meiotic inactivation of Xenopus Myt1 by CDK/XRINGO, but not CDK/cyclin, via site-specific phosphorylation.
    Ruiz EJ; Hunt T; Nebreda AR
    Mol Cell; 2008 Oct; 32(2):210-20. PubMed ID: 18951089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances and new directions in the discovery and development of cyclin-dependent kinase inhibitors.
    Fischer PM
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):623-34. PubMed ID: 12825457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
    Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
    Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute renal failure during sepsis: potential role of cell cycle regulation.
    Yang QH; Liu DW; Long Y; Liu HZ; Chai WZ; Wang XT
    J Infect; 2009 Jun; 58(6):459-64. PubMed ID: 19428114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of site-specific phosphorylation of the retinoblastoma protein during cell cycle progression.
    Boylan JF; Sharp DM; Leffet L; Bowers A; Pan W
    Exp Cell Res; 1999 Apr; 248(1):110-4. PubMed ID: 10094818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes.
    Adams PD; Li X; Sellers WR; Baker KB; Leng X; Harper JW; Taya Y; Kaelin WG
    Mol Cell Biol; 1999 Feb; 19(2):1068-80. PubMed ID: 9891042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of Cyclin-Dependent Kinase Fusion Complexes for In Vitro Analysis.
    Kõivomägi M
    Methods Mol Biol; 2021; 2329():95-109. PubMed ID: 34085218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.